VCM
TWST icon

Versant Capital Management’s Twist Bioscience TWST Stock Holding History

Versant Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Buy
289
+2
+0.7% +$130 ﹤0.01% 1721
2026
Q1 		$13.6K Buy
287
+181
+171% +$8.12K ﹤0.01% 2000
2025
Q4 		$3.36K Hold
106
– – ﹤0.01% 2360
2025
Q3 		$2.98K Hold
106
– – ﹤0.01% 2341
2025
Q2 		$3.9K Sell
106
-580
-85% -$20K ﹤0.01% 2245
2025
Q1 		$26.9K Buy
686
+580
+547% +$26.1K ﹤0.01% 1170
2024
Q4 		$4.93K Hold
106
– – ﹤0.01% 1769
2024
Q3 		$4.79K Hold
106
– – ﹤0.01% 1309
2024
Q2 		$5.22K Hold
106
– – ﹤0.01% 1204
2024
Q1 		$3.64K Hold
106
– – ﹤0.01% 1151
2023
Q4 		$3.91K Hold
106
– – ﹤0.01% 1055
2023
Q3 		$2.15K Hold
106
– – ﹤0.01% 1285
2023
Q2 		$2.17K Buy
+106
New +$1.59K ﹤0.01% 1350

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Versant Capital Management's TWST Position: Q2 2026 in Review

Versant Capital Management increased its Twist Bioscience (TWST) stake by 0.7% in Q2 2026, buying an estimated $130 and bringing the position to 289 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Versant Capital Management first reported a position in TWST in Q2 2023 and has held it in 13 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Versant Capital Management held 289 shares of Twist Bioscience worth $29.7K as of Q2 2026.
  • Versant Capital Management bought 2 Twist Bioscience shares in Q2 2026, an estimated $130.
  • Twist Bioscience made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1721 holding.
  • Versant Capital Management first reported a position in Twist Bioscience in Q2 2023 and has held it in 13 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.